论文部分内容阅读
目的:观察清热化痰汤治疗痰热闭肺型小儿肺炎的临床疗效。方法:将164例患儿随机分为2组各82例。对照组静脉滴注菌必治和病毒唑;治疗组在对照组治疗基础上加用清热化痰汤口服,疗程均为7天。结果:治愈率治疗组62.20%,对照组19.51%,2组比较,差异有非常显著性意义(P<0.01)。总有效率治疗组96.34%,对照组93.90%,2组比较,差异无显著性意义(P>0.01)。治疗后2组临床证候积分均明显降低,与治疗前比较,差异有非常显著性意义(P<0.01)。治疗后治疗组积分低于对照组,差异有显著性意义(P<0.05);治疗组治疗前后积分差值高于对照组,差异有显著性意义(P<0.05)。结论:清热化痰汤治疗痰热闭肺型小儿肺炎可缩短疗程,提高治愈率。
Objective: To observe the clinical efficacy of Qingre Huatan Decoction in treating phlebitis and pneumonia. Methods: 164 cases were randomly divided into two groups of 82 cases. The control group intravenous infusion of bacitracin and ribavirin; the treatment group in the control group plus Qingre Huatan decoction on the basis of oral treatment for 7 days. Results: The cure rate was 62.20% in the treatment group and 19.51% in the control group. There was significant difference between the two groups (P <0.01). The total effective rate was 96.34% in the treatment group and 93.90% in the control group. There was no significant difference between the two groups (P> 0.01). After treatment, the scores of clinical syndromes in both groups were significantly lower than those before treatment, the difference was significant (P <0.01). After treatment, the score of the treatment group was lower than that of the control group, the difference was significant (P <0.05). The score difference of the treatment group before and after treatment was higher than that of the control group, the difference was significant (P <0.05). Conclusion: Qingre Huatan Decoction in the treatment of phlegm-heat closed lung pneumonia can shorten the course of treatment and improve the cure rate.